Downregulation of the β1,3-galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy

Contributions to Nephrology

Volumn 157, Issue , 2007, Pages 120-124

  Inoue, Tatsuyuki ^a   Sugiyama, Hitoshi ^a   Kikumoto, Yoko ^a   Fukuoka, Naomi ^a   Maeshima, Yohei ^a   Hattori, Hisashi ^a   Fukushima, Kunihiro ^a   Nishizaki, Kazunori ^a   Hiki, Yoshiyuki ^b   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3GLC T GLUCOSYLTRANSFERASE, HUMAN; BETA3GLC-T GLUCOSYLTRANSFERASE, HUMAN; GLUCOSYLTRANSFERASE; IMMUNOGLOBULIN A; LECTIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BIOPSY; CYTOLOGY; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TONSIL;

B-LYMPHOCYTES; BIOPSY; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLOMERULONEPHRITIS, IGA; GLUCOSYLTRANSFERASES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; LECTINS; TONSIL;

EID: 34249048273     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102315     Document Type: Conference Paper

References (15)

1. Yoo EM, Morrison SL: IgA: an immune glycoprotein. Clin Immunol 2005;116:3-10.
2. Allen AC, Harper SJ, Feehally J: Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995;100:470-474.
3. Hiki Y, Kokubo T, Iwase H, et al: Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999;10:760-769.
4. Itoh A, Iwase H, Takatani T, et al: Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients. Nephrol Dial Transplant 2003;18:1108-1114.
5. Horie A, Hiki Y, Odani H, et al: IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis 2003;42:486-496.
6. Ju T, Cummings RD: A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA 2002;99:16613-16618.
7. Takahashi K, Asagoe K, Zaishun J, et al: Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am J Pathol 1998;153:745-755.
8. Yamana J, Yamamura M, Okamoto A, et al: Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2004;6:R567-R577.
9. Kobayashi M, Sugiyama H, Wang DH, et al: Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005;68:1018-1031.
10. Hiki Y, Odani H, Takahashi M, et al: Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001;59:1077-1085.
11. Xu LX, Zhao MH: Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 2005;68:167-172.
12. Ju T, Brewer K, D'Souza A, et al: Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem 2002;277:178-186.
13. Kudo T, Iwai T, Kubota T, et al: Molecular cloning and characterization of a novel UDP-Gal: GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J Biol Chem 2002;277:47724-47731.
14. Allen AC, Topham PS, Harper SJ, et al: Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 1997;12:701-706.
15. Tomana M, Matousovic K, Julian BA, et al: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997;52:509-516.